These outcomes, along with a prior report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two guidance the principle of targeting ACKR3 as a unique strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-relevant Diseases. We independently investigation, evaluation, and https://cicilc814hgb4.wikikali.com/user